About
Rachel Garlick holds a PhD in Immunology from Dartmouth College and has developed cancer immunotherapies. At Eris Biotech, she is building cancer drugs designed to activate immune responses against cancer.
Founder at Eris BiotechYC W24
Intro paths
YC
Rachel went through Y Combinator (Winter 2024) — any YC alum in your network can reach them through the YC community.
→
In turn, Rachel can intro founders to Eris Biotech's investors below.
Eris Biotech's investors · 1
Co-founders at Eris Biotech
EW
Evita WeagelFounder